Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Antex Biologics, Inc. (AMEX:ANX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider
Location
300 Professional Drive
Gaithersburg, MD 20879
Phone: (301) 590-0129
Fax: (301) 590-0731
Email: info@antexbiologics.com
Employees (last reported count): 25
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 38%
·Institutional: 3% (5% of float)
(7 institutions)
·Net Inst. Buying: 1,000  shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Antex Biologics, Inc., together with Antex Pharma Inc., a wholly owned subsidiary, is a biopharmaceutical company committed to developing and marketing new products to prevent and treat infections and related diseases. The Company concentrates on the development of products for bacterial infections. At its inception, the Company was focused on identifying key interactions between infectious bacteria and their host. Early discoveries lead to the development of two novel platform technologies, Antigen Receptor Technology and Nutriment Signal Transduction. The Company also has developed the Virulence Expression Profiling platform, which consists of the application of genomic expression profiling and functional genomics to identify and characterize disease-specific proteins (proteomics). These technologies form the basis for proprietary vaccine and therapeutic products.
More from Market Guide: Expanded Business Description

Financial Summary
Antex Biologics, Inc. is a biopharmaceutical company commited to the development of new products to prevent and treat infectious diseases and related disorders. For the six months ended 6/30/01, revenues fell 24% to $120 thousand. Net loss applicable to Common increased 7% to $3.9 million. Revenues reflect a reduction in the services requested by SmithKline Beecham. Higher loss reflects increased S/G/A costs due to increased personel.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

V. Esposito, Ph.D., 60
Chairman, CEO
$467K
Stephen Keith, M.D., 49
Pres, COO
--  
Jeffrey Pirone
CFO, Exec. VP
--  
W. James Jackson, P.h.D, 46
VP of Research
--  
Alan Liss, Ph.D.
VP, Product Devel.
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- AMEX:ANXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 2-Apr-2001
$0.85 
Recent Price$1.45 
52-Week High
on 5-Sep-2000
$6.375
Beta0.18 
Daily Volume (3-month avg)13.9K
Daily Volume (10-day avg)19.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-75.3%
52-Week Change
relative to S&P500
-66.9%
Share-Related Items
Market Capitalization$17.7M
Shares Outstanding12.2M
Float7.60M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 5 on 20-July-2000
Per-Share Data
Book Value (mrq)$0.62 
Earnings (ttm)-$0.81 
Earnings (mrq)-$0.14 
Sales (ttm)$0.03 
Cash (mrq)$0.61 
Valuation Ratios
Price/Book (mrq)2.35 
Price/EarningsN/A 
Price/Sales (ttm)51.52 
Income Statements
Sales (ttm)$313.0K
EBITDA (ttm)-$7.27M
Income available to common (ttm)-$8.88M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-56.54%
Return on Equity (ttm)-83.41%
Financial Strength
Current Ratio (mrq)6.07 
Debt/Equity (mrq)0 
Total Cash (mrq)$7.45M
Short Interest
As of 8-Aug-2001
Shares Short8,000 
Percent of Float0.1%
Shares Short
(Prior Month)
8,000 
Short Ratio0.57 
Daily Volume14.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.